Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
暂无分享,去创建一个
Cheng Luo | Sarah Spiegel | Ronen Marmorstein | M. Maceyka | S. Milstien | S. Spiegel | R. Marmorstein | K. Harikumar | C. Luo | T. Kordula | S. Singh | J. Allegood | G. Strub | Jeremy Allegood | Michael Maceyka | Sheldon Milstien | Nitai C Hait | Graham M Strub | Kuzhuvelil B Harikumar | Sandeep K Singh | Tomasz Kordula | N. Hait | Michael Maceyka
[1] E. Olson,et al. The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.
[2] A. Sharrocks,et al. MAP Kinase-Mediated c-fos Regulation Relies on a Histone Acetylation Relay Switch , 2008, Molecular cell.
[3] E. Albi,et al. Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus. , 2008, The Biochemical journal.
[4] E. Seto,et al. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men , 2008, Nature Reviews Molecular Cell Biology.
[5] J. Cyster,et al. Finding a way out: lymphocyte egress from lymphoid organs , 2007, Nature Immunology.
[6] S. Milstien,et al. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. , 2007, Cancer research.
[7] P. Marks,et al. Histone Deacetylase Inhibitors: Overview and Perspectives , 2007, Molecular Cancer Research.
[8] Huan Yu,et al. Protein Kinase D-mediated Phosphorylation and Nuclear Export of Sphingosine Kinase 2* , 2007, Journal of Biological Chemistry.
[9] S. Milstien,et al. Sphingosine Kinase Type 2 Activation by ERK-mediated Phosphorylation* , 2007, Journal of Biological Chemistry.
[10] S. Milstien,et al. Functions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives* , 2007, Journal of Biological Chemistry.
[11] S. Payne,et al. A rapid and sensitive method to measure secretion of sphingosine-1-phosphate. , 2007, Methods in enzymology.
[12] L. Mahadevan,et al. Enhanced histone acetylation and transcription: a dynamic perspective. , 2006, Molecular cell.
[13] Hugh Rosen,et al. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases. , 2006, Current pharmaceutical design.
[14] S. Minucci,et al. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.
[15] L. Ngo,et al. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] Sarah Spiegel,et al. Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.
[17] R. Irvine. Nuclear lipid signalling , 2003, Nature Reviews Molecular Cell Biology.
[18] D. O’Carroll,et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.
[19] S. Milstien,et al. Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform* , 2000, The Journal of Biological Chemistry.
[20] P. Marks,et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.
[21] J. Ashby. References and Notes , 1999 .
[22] L. Cocco,et al. Phospholipid interactions in rat liver nuclear matrix. , 1980, Biochemical and biophysical research communications.